Roselabs invests $68.29m to establish pre-filled syringe manufacturing plant
Commenting on further clearances, Roselabs Biosciences director Zameer Agarwal was quoted by The Hindu as saying that Roselabs is awaiting regulatory approvals from 35-40 countries. A drug delivery
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.